Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Effects of caffeine citrate on myelin basic protein in neonatal rats with hypoxic-ischemic brain damage].
Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain.
Reduced Retinal Nerve Fiber Layer Thickness and Macular Volume in Pediatric Multiple Sclerosis.
Multiple Sclerosis and CCSVI: A Population-Based Case Control Study.
Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis.
The role of IL-2 in the activation and expansion of regulatory T-cells and the development of experimental autoimmune encephalomyelitis.
Is There Extra Cost of Institutional Care for MS Patients?
Relationship between contrast sensitivity test and disease severity in multiple sclerosis patients.
The Retrovirus/Superantigen Hypothesis of Multiple Sclerosis.
Deep brain stimulation of the ventral intermediate nucleus of the thalamus for tremor in patients with multiple sclerosis.
Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica.
Relevance of brain lesion location to cognition in relapsing multiple sclerosis.
Multiple sclerosis imaging: recent advances.
Hypogeusia as a symptom of neuromyelitis optica spectrum disorder.
Novel Marmoset (Callithrix jacchus) Model of Human Herpesvirus 6A and 6B Infections: Immunologic, Virologic and Radiologic Characterization.
Multiple sclerosis: from molecules to treatment.
Frequency of reported European ancestry among multiple sclerosis patients from four cities in the southern and southeastern regions of Brazil.
Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.
Outcomes after Percutaneous Surgery for Patients with Multiple Sclerosis Related Trigeminal Neuralgia.
Multiple sclerosis: Spinal cord MRI indices correlate with outcome in MS.
Multiple sclerosis: Brain volume loss strengthens disease measure.
Antibodies target microvessels in neuromyelitis optica and multiple sclerosis patients.
Fibrinogen: A Circulating Factor in Search for Its Genetic Architecture.
Glial influence on the blood brain barrier.
Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial.

Pages